Increasingly selective pharmacologic targets in cardiovascular disease

Curr Atheroscler Rep. 2007 Aug;9(2):89-90. doi: 10.1007/s11883-007-0001-z.

Authors

Rodolfo Paoletti¹, Andrea Cignarella

Affiliation

¹ Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. rodolfo.paoletti@unimi.it

PMID: 17877914
DOI: 10.1007/s11883-007-0001-z

No abstract available

MeSH terms

Aged
Animals
Cardiovascular Diseases / drug therapy*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
Intracellular Signaling Peptides and Proteins / metabolism
Middle Aged
Protein Kinase Inhibitors / therapeutic use*
Protein Serine-Threonine Kinases / antagonists & inhibitors*
Protein Serine-Threonine Kinases / metabolism
Receptors, Estrogen / agonists
Receptors, Estrogen / metabolism*
Selective Estrogen Receptor Modulators / pharmacology*
Selective Estrogen Receptor Modulators / therapeutic use
rho-Associated Kinases

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Intracellular Signaling Peptides and Proteins
Protein Kinase Inhibitors
Receptors, Estrogen
Selective Estrogen Receptor Modulators
Protein Serine-Threonine Kinases
rho-Associated Kinases